This Web page located on the National Institute of Justice's Web site, contains a summary of the panel discussion on medication-assisted treatment for heroin and other opioid abusing offenders held in Washington, DC, on October 3, 2007. The primary objective of the meeting was to examine the use of opioids and treatment options for offenders who are incarcerated or under supervision in the community. Previous research has found that while counseling and other non-medication treatment therapies can be successful, the use of medications such as methadone and buprenorphine can also improve outcomes for offenders. Several issues that could affect the outcomes for offenders were raised during the discussion. These included the treatment philosophy of complete abstinence (clean and sober), the appropriateness of short-term (buprenorphine) vs. long-term (methadone) regimens, heroin (including injection drug) vs. other opioid (prescription drug) abusers, and nonclinical problems of compliance and improper use (boosting with alcohol and other drugs).
Downloads
No download available
Similar Publications
- Mental Health and Rape History in Relation to Non-Medical Use of Prescription Drugs in a National Sample of Women
- Identification and Health Risks of an Emerging Means of Drug Use in Correctional Facilities
- Cross-reactivity in urine of 53 cannabinoid analogs and metabolites using a carboxylic acid enzyme-linked immunosorbent assay (ELISA) and homogenous enzyme immunoassay (HEIA) kit and immunalysis synthetic cannabinoid HEIA kits